Literature DB >> 2654090

Three approaches to radiolabeling antibodies with 99mTc.

W C Eckelman1, C H Paik, J Steigman.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2654090     DOI： 10.1016/0883-2897(89)90192-x

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN： 0883-2897


× No keyword cloud information.
  3 in total

1.  Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.

Authors:  M A Stalteri; S J Mather
Journal:  Eur J Nucl Med       Date:  1996-02

2.  Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer.

Authors:  M Granowska; K E Britton; S J Mather; G Morris; D Ellison; S Soobramoney; I C Talbot; J M Northover
Journal:  Eur J Nucl Med       Date:  1993-08

3.  Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer.

Authors:  Victoria Calzada; Fernanda Garcia; Marcelo Fernández; Williams Porcal; Thomas Quinn; Omar Alonso; Juan Pablo Gambini; Pablo Cabral
Journal:  World J Nucl Med       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.